Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Owl Insights was a U.S. behavioral health technology company that developed measurement-based care and clinical analytics software for mental health providers and health systems. Its core product, The Owl, was a cloud-based platform used to collect patient-reported outcomes, support screening and monitoring, guide treatment decisions, and generate analytics across behavioral health workflows. The company focused on improving access, care quality, outcomes tracking, and cost management for behavioral health organizations preparing for value-based care. In June 2024, Owl was acquired by NeuroFlow, and the Owl website now states that Owl is part of NeuroFlow. The business appears to have been integrated into NeuroFlow's broader behavioral health measurement and engagement platform.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Owl Insights.